Apex Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-1,694,853
| Closed | -$5.97M | – | 260 |
|
|
2015
Q3 | $5.97M | Sell |
1,694,853
-519,261
| -23% | -$1.83M | 0.14% | 134 |
|
|
2015
Q2 | $22.1M | Buy |
2,214,114
+128,420
| +6% | +$1.28M | 0.47% | 73 |
|
|
2015
Q1 | $26.6M | Buy |
2,085,694
+241,940
| +13% | +$3.08M | 0.63% | 64 |
|
|
2014
Q4 | $26.1M | Buy |
1,843,754
+127,784
| +7% | +$1.81M | 0.7% | 56 |
|
|
2014
Q3 | $23.6M | Buy |
1,715,970
+596,798
| +53% | +$8.21M | 0.71% | 58 |
|
|
2014
Q2 | $17.2M | Buy |
1,119,172
+214,859
| +24% | +$3.3M | 0.53% | 70 |
|
|
2014
Q1 | $15.4M | Buy |
904,313
+91,912
| +11% | +$1.57M | 0.54% | 66 |
|
|
2013
Q4 | $10.5M | Buy |
+812,401
| New | +$10.5M | 0.39% | 76 |
|